Research Labs at the Healey Center

At the Sean M. Healey and AMG Center for ALS at Mass General, we are committed to radical change and acceleration of converting research into enduring treatments. Find information on our research studies and enroll in clinical trials.
8 results
  • research lab

HEALEY ALS Platform Trial

Borrowing from successes in cancer drug development, the Healey Center and NEALS faculty are leading the first ALS Platform Trial.

  • research lab


PREVENT ALS is an initiative with big goals: Stopping ALS in its tracks – before it begins.

  • research lab

Sean M. Healey & AMG Center Biorepository

The NEALS Biorepository/ALS Living Library at Mass General stores and shares over 100,000 plasma, serum, cerebro-spinal fluid and whole blood samples from people with ALS and controls for use by the ALS research community.

  • research lab

Lagier-Tourenne Lab: Clotide Lagier-Tourenne, MD, PHD

Clotilde Lagier-Tourenne performs patient-oriented research to understand the molecular mechanisms driving neurodegeneration in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) and to develop therapeutic strategies.

  • research lab

Neurological Clinical Research Institute

The Neurological Clinical Research Institute (NCRI) at Mass General is an academic research organization that designs, develops, facilitates and conducts multicenter clinical trials in neurological diseases.

Showing 1 - 8 of 8 results